Pfizer-BioNTech ask EU agency to OK vaccine for kids 5-11

Arne Müseler/Geovana Albuquerque/Health Agency (Brazil)/CC BY 2.0

Published October 15, 2021 8:01 AM

BERLIN (AP) — Pharmaceutical company Pfizer and biotechnology company BioNTech have requested to have their coronavirus vaccine licensed for children ages 5 to 11 across the European Union.

If EU regulators agree, it would be the first opportunity for younger children in Europe to get immunized against COVID-19.

Pfizer and BioNTech said Friday they have submitted data to support their request to the European Medicines Agency.

The information includes late-stage results from a study testing their COVID-19 vaccine in more than 2,200 children ages 6 months to 11 years.

There are currently no COVID-19 vaccines licensed for use in children younger than 12 in Europe or North America.

Article Topic Follows: National-World

Jump to comments ↓

The Associated Press

BE PART OF THE CONVERSATION

KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.